BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A 2020;117:31189-97. [PMID: 33229547 DOI: 10.1073/pnas.2017152117] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 2022:S1097-2765(22)00260-X. [PMID: 35390277 DOI: 10.1016/j.molcel.2022.03.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
2 Song Y, Tian S, Zhang P, Zhang N, Shen Y, Deng J. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia. Front Genet 2022;12:708699. [DOI: 10.3389/fgene.2021.708699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhang J, Xi J, Huang P, Zeng S. Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer. Front Med (Lausanne) 2021;8:644053. [PMID: 33748162 DOI: 10.3389/fmed.2021.644053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Qi Y, Zhang X, Wu Z, Tian M, Chen F, Guan W, Zhang S. Ferroptosis Regulation by Nutrient Signalling. Nutr Res Rev 2021;:1-13. [PMID: 34233775 DOI: 10.1017/S0954422421000226] [Reference Citation Analysis]
5 Yao X, Li W, Fang, Xiao C, Wu X, Li M, Luo Z. Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells. Adv Sci (Weinh) 2021;8:e2100997. [PMID: 34632727 DOI: 10.1002/advs.202100997] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
6 Shi J, Lai D, Zuo X, Liu D, Chen B, Zheng Y, Lu C, Gu X. Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma. Front Cell Dev Biol 2022;10:817643. [PMID: 35174152 DOI: 10.3389/fcell.2022.817643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang S, Wei W, Ma N, Qu Y, Liu Q. Molecular mechanisms of ferroptosis and its role in prostate cancer therapy. Crit Rev Oncol Hematol 2022;176:103732. [PMID: 35697233 DOI: 10.1016/j.critrevonc.2022.103732] [Reference Citation Analysis]
8 Tu Z, Li J, Long X, Wu L, Zhu X, Huang K, Rai SN. Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/9408886] [Reference Citation Analysis]
9 Hao J, Zhang W, Huang Z. Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Bioengineered 2022;13:6794-806. [PMID: 35246010 DOI: 10.1080/21655979.2022.2036909] [Reference Citation Analysis]
10 Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 2022;185:2401-21. [PMID: 35803244 DOI: 10.1016/j.cell.2022.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhao Q, Lin X, Wang G. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol 2022;12:952371. [DOI: 10.3389/fonc.2022.952371] [Reference Citation Analysis]
12 Dey S, Singh AK, Singh AK, Rawat K, Banerjee J, Agnihotri V, Upadhaya D. Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention. Med Oncol 2022;39. [DOI: 10.1007/s12032-021-01633-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang Y, Shen Z, Zhao S, Huang D, Wang X, Wu Y, Pei C, Shi S, Jia N, He Y, Wang Z. Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approach. Ecotoxicol Environ Saf 2022;239:113615. [PMID: 35567927 DOI: 10.1016/j.ecoenv.2022.113615] [Reference Citation Analysis]
14 Wang L, Ouyang S, Li B, Wu H, Wang F. GSK-3β manipulates ferroptosis sensitivity by dominating iron homeostasis. Cell Death Discov 2021;7:334. [PMID: 34732689 DOI: 10.1038/s41420-021-00726-3] [Reference Citation Analysis]
15 Shao C, Liu Y, Chen Z, Qin Y, Wang X, Wang X, Yan C, Zhu HL, Zhao J, Qian Y. 3D two-photon brain imaging reveals dihydroartemisinin exerts antiepileptic effects by modulating iron homeostasis. Cell Chem Biol 2021:S2451-9456(21)00520-1. [PMID: 34936859 DOI: 10.1016/j.chembiol.2021.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Patra S, Elahi N, Armorer A, Arunachalam S, Omala J, Hamid I, Ashton AW, Joyce D, Jiao X, Pestell RG. Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors. Front Oncol 2021;11:700629. [PMID: 34631530 DOI: 10.3389/fonc.2021.700629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jiang Z, Song X, Wei Y, Li Y, Kong D, Sun J. N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer. Bioengineered 2022;13:14460-71. [PMID: 35758158 DOI: 10.1080/21655979.2022.2088497] [Reference Citation Analysis]
18 Li S, Xu X, Zhang R, Huang Y. Identification of co-expression hub genes for ferroptosis in kidney renal clear cell carcinoma based on weighted gene co-expression network analysis and The Cancer Genome Atlas clinical data. Sci Rep 2022;12:4821. [PMID: 35314744 DOI: 10.1038/s41598-022-08950-2] [Reference Citation Analysis]
19 He D, Liao S, Xiao L, Cai L, You M, He L, Huang W. Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:739011. [PMID: 34790661 DOI: 10.3389/fcell.2021.739011] [Reference Citation Analysis]
20 Liu M, Li H, Wang X, Xia R, Li X, Ma Y, Wang M, Zhang H. TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gong Z, Liu Z, Du K, Wu J, Yang N, Shu J. Potential of β-elemene induced ferroptosis through Pole2-mediated p53 and PI3K/AKT signaling in lung cancer cells. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.110088] [Reference Citation Analysis]
22 Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell 2021. [PMID: 33891303 DOI: 10.1007/s13238-021-00841-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
23 Leu JI, Murphy ME, George DL. P53 regulates cellular redox state, ferroptosis and metabolism. Mol Cell Oncol 2021;8:1877076. [PMID: 33860080 DOI: 10.1080/23723556.2021.1877076] [Reference Citation Analysis]
24 Wang S, Chen S, Ying Y, Ma X, Shen H, Li J, Wang X, Lin Y, Liu B, Zheng X, Xie L. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol 2021;9:676142. [PMID: 34291048 DOI: 10.3389/fcell.2021.676142] [Reference Citation Analysis]
25 Ge M, Niu J, Hu P, Tong A, Dai Y, Xu F, Li F. A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer. Front Med (Lausanne) 2021;8:637743. [PMID: 33928101 DOI: 10.3389/fmed.2021.637743] [Reference Citation Analysis]
26 Küçüksayan E, Sansone A, Chatgilialoglu C, Ozben T, Tekeli D, Talibova G, Ferreri C. Sapienic Acid Metabolism Influences Membrane Plasticity and Protein Signaling in Breast Cancer Cell Lines. Cells 2022;11:225. [DOI: 10.3390/cells11020225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zhao S, Li P, Wu W, Wang Q, Qian B, Li X, Shen M. Roles of ferroptosis in urologic malignancies. Cancer Cell Int 2021;21:676. [PMID: 34922551 DOI: 10.1186/s12935-021-02264-5] [Reference Citation Analysis]
28 Walkowski B, Kleibert M, Majka M, Wojciechowska M. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. Cells 2022;11:1553. [DOI: 10.3390/cells11091553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lin Z, Liu J, Kang R, Yang M, Tang D. Lipid Metabolism in Ferroptosis. Adv Biol (Weinh) 2021;5:e2100396. [PMID: 34015188 DOI: 10.1002/adbi.202100396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Yan Y, Lei G, Gan B. A mTORC1-mediated cyst(e)ine sensing mechanism governing GPX4 synthesis and ferroptosis. Mol Cell Oncol 2021;8:1919006. [PMID: 34027051 DOI: 10.1080/23723556.2021.1919006] [Reference Citation Analysis]
31 Khan MW, Zou C, Hassan S, Din FU, Abdoul Razak MY, Nawaz A, Alam Zeb, Wahab A, Bangash SA. Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO 3 nanoparticles for synergistic chemotherapy. RSC Adv 2022;12:14808-18. [DOI: 10.1039/d2ra00742h] [Reference Citation Analysis]
32 Vaidyanathan S, Salmi TM, Sathiqu RM, McConville MJ, Cox AG, Brown KK. YAP regulates an SGK1/mTORC1/SREBP-dependent lipogenic program to support proliferation and tissue growth. Dev Cell 2022:S1534-5807(22)00070-3. [PMID: 35216681 DOI: 10.1016/j.devcel.2022.02.004] [Reference Citation Analysis]
33 Li R, Li Y, Yang X, Hu Y, Yu H, Li Y. Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway. J Transl Med 2022;20:341. [PMID: 35907871 DOI: 10.1186/s12967-022-03540-2] [Reference Citation Analysis]
34 Li M, Huang L, Li Y, Luo L. Editorial: Implications of Ferroptosis-Related Genes to the Genetics of Cancer Development. Front Genet 2022;13:952340. [DOI: 10.3389/fgene.2022.952340] [Reference Citation Analysis]
35 Li L, Wang X. Ferroptosis‐associated cholesterol metabolism regulated by p85α in human bronchial epithelial cells with smoking. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.30] [Reference Citation Analysis]
36 Thompson HJ, Neil ES, McGinley JN. Pre-Clinical Insights into the Iron and Breast Cancer Hypothesis. Biomedicines 2021;9:1652. [PMID: 34829880 DOI: 10.3390/biomedicines9111652] [Reference Citation Analysis]
37 Menendez JA, Lupu R. Fatty acid synthase: A druggable driver of breast cancer brain metastasis. Expert Opin Ther Targets 2022. [PMID: 35545806 DOI: 10.1080/14728222.2022.2077189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lin L, An L, Chen H, Feng L, Lu M, Liu Y, Chu C, Shan J, Xie T, Wang X, Wang S. Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation. Front Pharmacol 2021;12:777689. [PMID: 34925035 DOI: 10.3389/fphar.2021.777689] [Reference Citation Analysis]
39 Yangyun W, Guowei S, Shufen S, Jie Y, Rui Y, Yu R. Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma. Gene 2022;809:145992. [PMID: 34648917 DOI: 10.1016/j.gene.2021.145992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Chen X, Yu C, Kang R, Kroemer G, Tang D. Cellular degradation systems in ferroptosis. Cell Death Differ. 2021;. [PMID: 33462411 DOI: 10.1038/s41418-020-00728-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
41 Li X, Huang Z, Zhu L, Yu F, Feng M, Gu A, Jiang J, Wang G, Huang D. Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas. Front Genet 2022;13:905751. [DOI: 10.3389/fgene.2022.905751] [Reference Citation Analysis]
42 Cheng H, Wang M, Su J, Li Y, Long J, Chu J, Wan X, Cao Y, Li Q. Lipid Metabolism and Cancer. Life 2022;12:784. [DOI: 10.3390/life12060784] [Reference Citation Analysis]
43 Shao Y, Jia H, Li S, Huang L, Aikemu B, Yang G, Zhang S, Sun J, Zheng M. Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer. Oxid Med Cell Longev 2021;2021:7007933. [PMID: 34745421 DOI: 10.1155/2021/7007933] [Reference Citation Analysis]
44 Uemura N, Hayashi H, Baba H. Statin as a therapeutic agent in gastroenterological cancer. World J Gastrointest Oncol 2022; 14(1): 110-123 [DOI: 10.4251/wjgo.v14.i1.110] [Reference Citation Analysis]
45 Gan B. Mitochondrial regulation of ferroptosis. J Cell Biol 2021;220:e202105043. [PMID: 34328510 DOI: 10.1083/jcb.202105043] [Reference Citation Analysis]
46 Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R, Jiang L. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutatnt colorectal cancer. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102426] [Reference Citation Analysis]
47 Wang Y, Zhao Y, Ye T, Yang L, Shen Y, Li H. Ferroptosis Signaling and Regulators in Atherosclerosis. Front Cell Dev Biol 2021;9:809457. [PMID: 34977044 DOI: 10.3389/fcell.2021.809457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Wang X, Wang Y, Li Z, Qin J, Wang P. Regulation of Ferroptosis Pathway by Ubiquitination. Front Cell Dev Biol 2021;9:699304. [PMID: 34485285 DOI: 10.3389/fcell.2021.699304] [Reference Citation Analysis]
49 Sun D, Li YC, Zhang XY. Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer. Front Pharmacol 2021;12:681223. [PMID: 34122108 DOI: 10.3389/fphar.2021.681223] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Pradeepa, Suresh V, Senapati S, Chakraborty S. AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis. Cell Oncol (Dordr) 2022. [PMID: 35834097 DOI: 10.1007/s13402-022-00690-9] [Reference Citation Analysis]
51 Wang F, Graham ET, Naowarojna N, Shi Z, Wang Y, Xie G, Zhou L, Salmon W, Jia JM, Wang X, Huang Y, Schreiber SL, Zou Y. PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ. Cell Chem Biol 2021:S2451-9456(21)00478-5. [PMID: 34813762 DOI: 10.1016/j.chembiol.2021.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
52 Zhang Y, Qin P, Xu X, Li M, Huang H, Yan J, Zhou Y. Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway. Front Oncol 2021;11:792285. [PMID: 35047403 DOI: 10.3389/fonc.2021.792285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Liu SJ, Yang YB, Zhou JX, Lin YJ, Pan YL, Pan JH. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer. Dis Markers 2021;2021:2385406. [PMID: 34868391 DOI: 10.1155/2021/2385406] [Reference Citation Analysis]
54 Tan S, Kong Y, Xian Y, Gao P, Xu Y, Wei C, Lin P, Ye W, Li Z, Zhu X. The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends? Front Mol Biosci 2022;9:938677. [DOI: 10.3389/fmolb.2022.938677] [Reference Citation Analysis]
55 Chen X, Kang R, Kroemer G, Tang D. Organelle-specific regulation of ferroptosis. Cell Death Differ 2021;28:2843-56. [PMID: 34465893 DOI: 10.1038/s41418-021-00859-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Bu Y, Wu H, Deng R, Wang Y. The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN. Inflammopharmacology 2022. [PMID: 35389123 DOI: 10.1007/s10787-022-00975-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Shi Z, Naowarojna N, Pan Z, Zou Y. Multifaceted mechanisms mediating cystine starvation-induced ferroptosis. Nat Commun 2021;12:4792. [PMID: 34373463 DOI: 10.1038/s41467-021-25159-5] [Reference Citation Analysis]
58 Yan YC, Meng GX, Ding ZN, Liu YF, Chen ZQ, Yan LJ, Yang YF, Liu H, Yang CC, Dong ZR, Hong JG, Li T. Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies. J Cancer 2022;13:88-101. [PMID: 34976173 DOI: 10.7150/jca.65574] [Reference Citation Analysis]
59 Feng D, Shi X, Xiong Q, Zhang F, Li D, Wei W, Yang L. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. Front Cell Dev Biol 2022;10:803766. [DOI: 10.3389/fcell.2022.803766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Chen L, Guo Y, Wu Z, Zhao S, Zhang Z, Zheng F, Sun L, Hao Z, Xu C, Wang T, Peng Y. Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells. Acta Biochim Biophys Sin (Shanghai) 2021;53:1662-9. [PMID: 34718375 DOI: 10.1093/abbs/gmab144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Luis G, Godfroid A, Nishiumi S, Cimino J, Blacher S, Maquoi E, Wery C, Collignon A, Longuespée R, Montero-Ruiz L, Dassoul I, Maloujahmoum N, Pottier C, Mazzucchelli G, Depauw E, Bellahcène A, Yoshida M, Noel A, Sounni NE. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol 2021;43:102006. [PMID: 34030117 DOI: 10.1016/j.redox.2021.102006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Kandel P, Semerci F, Mishra R, Choi W, Bajic A, Baluya D, Ma L, Chen K, Cao AC, Phongmekhin T, Matinyan N, Jiménez-Panizo A, Chamakuri S, Raji IO, Chang L, Fuentes-Prior P, MacKenzie KR, Benn CL, Estébanez-Perpiñá E, Venken K, Moore DD, Young DW, Maletic-Savatic M. Oleic acid is an endogenous ligand of TLX/NR2E1 that triggers hippocampal neurogenesis. Proc Natl Acad Sci U S A 2022;119:e2023784119. [PMID: 35333654 DOI: 10.1073/pnas.2023784119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
63 Centonze G, Natalini D, Piccolantonio A, Salemme V, Morellato A, Arina P, Riganti C, Defilippi P. Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression. Front Oncol 2022;12:906670. [PMID: 35719918 DOI: 10.3389/fonc.2022.906670] [Reference Citation Analysis]
64 Harandi-Zadeh S, Boycott C, Beetch M, Yang T, Martin BJE, Ren K, Kwasniak A, Dupuis JH, Lubecka K, Yada RY, Howe LJ, Stefanska B. Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells. Antioxidants (Basel) 2021;10:1232. [PMID: 34439480 DOI: 10.3390/antiox10081232] [Reference Citation Analysis]
65 Liu Z, Li T, Li N, Wang Y, Chen L, Tang X, Wan M, Mao C. GSH-induced chemotaxis nanomotors for cancer treatment by ferroptosis strategy. Sci China Chem . [DOI: 10.1007/s11426-021-1208-6] [Reference Citation Analysis]
66 Fan X, Ou Y, Liu H, Zhan L, Zhu X, Cheng M, Li Q, Yin D, Liao L. A Ferroptosis-Related Prognostic Signature Based on Antitumor Immunity and Tumor Protein p53 Mutation Exploration for Guiding Treatment in Patients With Head and Neck Squamous Cell Carcinoma. Front Genet 2021;12:732211. [PMID: 34616431 DOI: 10.3389/fgene.2021.732211] [Reference Citation Analysis]
67 Feng Q, Yu X, Qiao Y, Pan S, Wang R, Zheng B, Wang H, Ren KD, Liu H, Yang Y. Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials. Front Pharmacol 2022;13:858676. [PMID: 35517803 DOI: 10.3389/fphar.2022.858676] [Reference Citation Analysis]
68 Wu F, Xiong G, Chen Z, Lei C, Liu Q, Bai Y. SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway. Hereditas 2022;159. [DOI: 10.1186/s41065-022-00225-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Song X, Xin S, Zhang Y, Mao J, Duan C, Cui K, Chen L, Li F, Liu Z, Wang T, Liu J, Liu X, Song W. Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer. Front Cell Dev Biol 2022;10:810272. [PMID: 35265613 DOI: 10.3389/fcell.2022.810272] [Reference Citation Analysis]
70 Raeisi M, Hassanbeigi L, Khalili F, Kharrati-Shishavan H, Yousefi M, Mehdizadeh A. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma. Mol Biol Rep 2022. [PMID: 35906508 DOI: 10.1007/s11033-021-07094-2] [Reference Citation Analysis]
71 Yamamoto Y, Sakurai T, Chen Z, Inoue N, Chiba H, Hui S. Lysophosphatidylethanolamine Affects Lipid Accumulation and Metabolism in a Human Liver-Derived Cell Line. Nutrients 2022;14:579. [DOI: 10.3390/nu14030579] [Reference Citation Analysis]
72 Kim MJ, Yun GJ, Kim SE. Metabolic Regulation of Ferroptosis in Cancer. Biology (Basel) 2021;10:83. [PMID: 33499222 DOI: 10.3390/biology10020083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Basu A, Lambring CB. Akt Isoforms: A Family Affair in Breast Cancer. Cancers (Basel) 2021;13:3445. [PMID: 34298660 DOI: 10.3390/cancers13143445] [Reference Citation Analysis]
74 Dietrich C, Hofmann TG. Ferroptosis Meets Cell-Cell Contacts. Cells 2021;10:2462. [PMID: 34572111 DOI: 10.3390/cells10092462] [Reference Citation Analysis]
75 Ren M, Wang L, Gao Z, Deng X, Shen K, Li Y, Ding Y, Wei C, Gu J. Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid. Bioengineered 2022;13:13571-86. [DOI: 10.1080/21655979.2022.2080385] [Reference Citation Analysis]
76 Yu L, He M, Liu S, Dou X, Li L, Gu N, Li B, Liu Z, Wang G, Fan J. Fluorescent Egg White-Based Carbon Dots as a High-Sensitivity Iron Chelator for the Therapy of Nonalcoholic Fatty Liver Disease by Iron Overload in Zebrafish. ACS Appl Mater Interfaces 2021;13:54677-89. [PMID: 34756030 DOI: 10.1021/acsami.1c14674] [Reference Citation Analysis]
77 Wang G, Qin S, Zheng Y, Xia C, Zhang P, Zhang L, Yao J, Yi Y, Deng L. T-2 Toxin Induces Ferroptosis by Increasing Lipid Reactive Oxygen Species (ROS) and Downregulating Solute Carrier Family 7 Member 11 (SLC7A11). J Agric Food Chem 2021;69:15716-27. [PMID: 34918923 DOI: 10.1021/acs.jafc.1c05393] [Reference Citation Analysis]
78 Chen W, Chen Y, Liu L, Wu Y, Fu P, Cao Y, Xiong J, Tu Y, Li Z, Liu Y, Jie Z, Jurisic V. Comprehensive Analysis of Immune Infiltrates of Ferroptosis-Related Long Noncoding RNA and Prediction of Colon Cancer Patient Prognoses. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/9480628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Zhi Y, Zhang S, Zi M, Wang Y, Liu Y, Zhang M, Shi L, Yan Q, Zeng Z, Xiong W, Zhi K, Gong Z. Potential applications of N6 -methyladenosine modification in the prognosis and treatment of cancers via modulating apoptosis, autophagy, and ferroptosis. Wiley Interdiscip Rev RNA 2022;:e1719. [PMID: 35114735 DOI: 10.1002/wrna.1719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metabolism 2022. [DOI: 10.1016/j.cmet.2022.01.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 19.0] [Reference Citation Analysis]
81 Cai Y, Wu S, Jia Y, Pan X, Li C, Cui D. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/1249290] [Reference Citation Analysis]
82 Xl L, Gy Z, R G, N C. Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential. Front Immunol 2022;13:956361. [DOI: 10.3389/fimmu.2022.956361] [Reference Citation Analysis]
83 Chen D, Gao W, Zang L, Zhang X, Li Z, Zhu H, Yu X. Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients. Front Cell Dev Biol 2022;10:819724. [DOI: 10.3389/fcell.2022.819724] [Reference Citation Analysis]
84 Chafe SC, Vizeacoumar FS, Venkateswaran G, Nemirovsky O, Awrey S, Brown WS, McDonald PC, Carta F, Metcalfe A, Karasinska JM, Huang L, Muthuswamy SK, Schaeffer DF, Renouf DJ, Supuran CT, Vizeacoumar FJ, Dedhar S. Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv 2021;7:eabj0364. [PMID: 34452919 DOI: 10.1126/sciadv.abj0364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
85 Chen ZA, Tian H, Yao DM, Zhang Y, Feng ZJ, Yang CJ. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Front Oncol 2021;11:738477. [PMID: 34568075 DOI: 10.3389/fonc.2021.738477] [Reference Citation Analysis]
86 Read GH, Bailleul J, Vlashi E, Kesarwala AH. Metabolic response to radiation therapy in cancer. Mol Carcinog 2021. [PMID: 34961986 DOI: 10.1002/mc.23379] [Reference Citation Analysis]
87 Chen X, Kang R, Kroemer G, Tang D. Ferroptosis in infection, inflammation, and immunity. J Exp Med 2021;218:e20210518. [PMID: 33978684 DOI: 10.1084/jem.20210518] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
88 Ye L, Jin F, Kumar SK, Dai Y. The mechanisms and therapeutic targets of ferroptosis in cancer. Expert Opin Ther Targets 2021;:1-22. [PMID: 34821176 DOI: 10.1080/14728222.2021.2011206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
89 Jiang J, Gao S, Han T, Tang M. Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hCG) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/7933166] [Reference Citation Analysis]
90 Liu J, Nie C. KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma. Anticancer Drugs 2022. [PMID: 35946516 DOI: 10.1097/CAD.0000000000001329] [Reference Citation Analysis]
91 Gai Z, Wang Y, Wang J, Fu J, Tian L, Li X, Zhao J, Gong G. Downregulation of CASTOR1 Inhibits Heat-Stress-Induced Apoptosis and Promotes Casein and Lipid Synthesis in Mammary Epithelial Cells. J Agric Food Chem 2022;70:5386-95. [PMID: 35442666 DOI: 10.1021/acs.jafc.2c00877] [Reference Citation Analysis]
92 Leu JI, Murphy ME, George DL. Targeting ErbB3 and Cellular NADPH/NADP+ Abundance Sensitizes Cutaneous Melanomas to Ferroptosis Inducers. ACS Chem Biol 2022;17:1038-44. [PMID: 35420772 DOI: 10.1021/acschembio.2c00113] [Reference Citation Analysis]
93 Fang K, Du S, Shen D, Xiong Z, Jiang K, Liang D, Wang J, Xu H, Hu L, Zhai X, Jiang Y, Xia Z, Xie C, Jin D, Cheng W, Meng S, Wang Y. SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway. iScience 2022;25:104618. [DOI: 10.1016/j.isci.2022.104618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Dai W, Xiang W, Han L, Yuan Z, Wang R, Ma Y, Yang Y, Cai S, Xu Y, Mo S, Li Q, Cai G. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Commun (Lond) 2022. [PMID: 35904817 DOI: 10.1002/cac2.12341] [Reference Citation Analysis]
95 Tao J, Li C, Zheng Y, Wang F, Zhang M, Wu X, Chen Y, Zeng Q, Chen F, Fei W. Biological protein mediated ferroptotic tumor nanotherapeutics. J Mater Chem B 2021;9:9262-84. [PMID: 34730601 DOI: 10.1039/d1tb01289d] [Reference Citation Analysis]
96 Wang Y, Chen J, Lu J, Xi J, Xu Z, Fan L, Dai H, Gao L. Metal ions/nucleotide coordinated nanoparticles comprehensively suppress tumor by synergizing ferroptosis with energy metabolism interference. J Nanobiotechnology 2022;20:199. [PMID: 35473696 DOI: 10.1186/s12951-022-01405-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Hao J, Bei J, Li Z, Han M, Ma B, Ma P, Zhou X. Qing`e Pill Inhibits Osteoblast Ferroptosis via ATM Serine/Threonine Kinase (ATM) and the PI3K/AKT Pathway in Primary Osteoporosis. Front Pharmacol 2022;13:902102. [DOI: 10.3389/fphar.2022.902102] [Reference Citation Analysis]
98 Huang C, Zhan L. Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer. Front Pharmacol 2022;13:851540. [DOI: 10.3389/fphar.2022.851540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 2022. [PMID: 35338310 DOI: 10.1038/s41568-022-00459-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
100 Zhang L, Jia R, Li H, Yu H, Ren K, Jia S, Li Y, Wang Q. Insight into the Double-Edged Role of Ferroptosis in Disease. Biomolecules 2021;11:1790. [PMID: 34944434 DOI: 10.3390/biom11121790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Lei G, Zhuang L, Gan B. mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential. Bioessays 2021;43:e2100093. [PMID: 34121197 DOI: 10.1002/bies.202100093] [Reference Citation Analysis]
102 Li B, Zhang X, Ren Q, Gao L, Tian J. NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways. Front Pharmacol 2021;12:781623. [PMID: 35082669 DOI: 10.3389/fphar.2021.781623] [Reference Citation Analysis]
103 Xing XL, Liu Y, Liu J, Zhou H, Zhang H, Zuo Q, Bu P, Duan T, Zhou Y, Xiao Z. Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma. Front Immunol 2022;13:851312. [PMID: 35619698 DOI: 10.3389/fimmu.2022.851312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Wang G, Wang JJ, Xu XN, Shi F, Fu XL. Targeting cellular energy metabolism- mediated ferroptosis by small molecule compounds for colorectal cancer therapy. J Drug Target 2022;:1-14. [PMID: 35481396 DOI: 10.1080/1061186X.2022.2071909] [Reference Citation Analysis]
105 Zhao Y, Liang Y, Xu Z, Liu J, Liu X, Ma J, Sun C, Yang Y. Exosomal miR-673-5p from fibroblasts promotes Schwann cell-mediated peripheral neuron myelination by targeting the TSC2/mTORC1/SREBP2 axis. J Biol Chem 2022;298:101718. [PMID: 35151688 DOI: 10.1016/j.jbc.2022.101718] [Reference Citation Analysis]
106 Teixeira LD, Torrez Lamberti MF, DeBose-Scarlett E, Bahadiroglu E, Garrett TJ, Gardner CL, Meyer JL, Lorca GL, Gonzalez CF. Lactobacillus johnsonii N6.2 and Blueberry Phytophenols Affect Lipidome and Gut Microbiota Composition of Rats Under High-Fat Diet. Front Nutr 2021;8:757256. [PMID: 34722616 DOI: 10.3389/fnut.2021.757256] [Reference Citation Analysis]
107 Gao M, Fan K, Chen Y, Zhang G, Chen J, Zhang Y. Understanding the mechanistic regulation of ferroptosis in cancer: gene matters. J Genet Genomics 2022:S1673-8527(22)00160-6. [PMID: 35697272 DOI: 10.1016/j.jgg.2022.06.002] [Reference Citation Analysis]
108 Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L. Ferroptosis in cancer and cancer immunotherapy. Cancer Communications 2022;42:88-116. [DOI: 10.1002/cac2.12250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
109 Li X, Liu Z, Xia C, Yan K, Fang Z, Fan Y. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC. Cancer Lett 2021;527:150-63. [PMID: 34942305 DOI: 10.1016/j.canlet.2021.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]